Amhr2tm1(EGFP/cre/ERT2)Wtsi
Targeted Allele Detail
|
Symbol: |
Amhr2tm1(EGFP/cre/ERT2)Wtsi |
Name: |
anti-Mullerian hormone type 2 receptor; targeted mutation 1, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:7867271 |
Gene: |
Amhr2 Location: Chr15:102353802-102363068 bp, + strand Genetic Position: Chr15, 57.58 cM
|
Alliance: |
Amhr2tm1(EGFP/cre/ERT2)Wtsi page
|
|
Mutant Cell Line: |
CEPD0047_3_B06 |
Germline Transmission: |
Earliest citation of germline transmission:
J:82809
|
Parent Cell Line: |
JM8.N4 (ES Cell)
|
Strain of Origin: |
C57BL/6N
|
|
Allele Type: |
|
Targeted (Conditional ready, Inducible, Null/knockout, Recombinase, Reporter) |
Inducer: |
|
tamoxifen |
Mutation: |
|
Insertion
|
|
|
Amhr2tm1(EGFP/cre/ERT2)Wtsi expression driven by
1 gene
Knock-in expression driven by:
Organism |
Driver Gene |
Note |
mouse |
Amhr2 (MGI:105062) |
|
|
|
|
Mutation details: The following elements were inserted into intron 6: FRT site, En2 splice acceptor sequence, sequence coding for F2A self-cleaving peptide, EGFP reporter gene, sequence coding for T2A self-cleaving peptide, cre/ERT2 inducible recombinase gene, SV40 poly(A) signal sequence, Rox site flanked puromycin resistance gene cassette, and a loxP site. A second loxP site was inserted into intron 11. This creates a reporter-recombinase knockout allele with floxed exons 7-11.
(J:82809)
|
|
|
Activity: |
 Tissue activity of this recombinase allele
|
Driver:
|
Amhr2
(mouse)
|
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Amhr2 Mutation: |
29 strains or lines available
|
|
Original: |
J:82809 European Mouse Mutant Archive, Information obtained from the European Mouse Mutant Archive (EMMA). Unpublished. 2003-2013; |
All: |
1 reference(s) |
|